Showing results (1711-1720 of 1,771) with videos related to
Sort By:
Pageof 178
Blood|November 20, 2012
Canonical Wnt signaling in megakaryocytes regulates proplatelet formationIain C Macaulay, Jonathan N Thon, Marloes R Tijssen, et al.Molecular Nutrition & Food Research|July 9, 2016
A casein hydrolysate protects mice against high fat diet induced hyperglycemia by attenuating NLRP3 inflammasome-mediated inflammation and improving insulin signalingNiamh P Healy, Anna M Kirwan, Maeve A McArdle, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 10, 2017
Cetuximab Plus Chemoradiotherapy in Immunocompetent Patients With Anal Carcinoma: A Phase II Eastern Cooperative Oncology Group-American College of Radiology Imaging Network Cancer Research Group Trial (E3205)Madhur K Garg, Fengmin Zhao, Joseph A Sparano, et al.Cancer|March 1, 1978
The value of diagnostic aids in detecting pancreas cancerP J Fitzgerald, J G Fortner, R C Watson, et al.Dermatologic Clinics|November 21, 2007
Radiation therapy toxicity to the skinT J Fitzgerald, Maryann Bishop Jodoin, Gayle Tillman, et al.Cancer Medicine|March 14, 2018
Population-based differences in the outcome and presentation of lung cancer patients based upon racial, histologic, and economic factors in all lung patients and those with metastatic diseaseJohn Michael Varlotto, Richard Voland, Kerrie McKie, et al.Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|March 15, 2024
Association between CFTR modulators and changes in iron deficiency markers in cystic fibrosisShijing Jia, Yizhuo Wang, Melissa H Ross, et al.Blood|July 2, 2002
Low-dose total body irradiation followed by allogeneic lymphocyte infusion may induce remission in patients with refractory hematologic malignancyKaren K Ballen, Pamela S Becker, Robert V B Emmons, et al.Circulation|February 19, 1998
'Optimal' directional coronary atherectomy: final results of the Optimal Atherectomy Restenosis Study (OARS)C A Simonton, M B Leon, D S Baim, et al.Circulation. Cardiovascular Interventions|November 11, 2010
Six-month results of the NEVO Res-Elution I (NEVO RES-I) trial: a randomized, multicenter comparison of the NEVO sirolimus-eluting coronary stent with the TAXUS Liberté paclitaxel-eluting stent in de novo native coronary artery lesionsJohn A Ormiston, Alexandre Abizaid, John Spertus, et al.Pageof 178